Belfast · Northern Ireland
TheBELFAST HERALDLocal knowledge. National perspective.
Retrospective archiveHistorical reports were compiled from linked contemporaneous sources. Dates refer to the events covered.How the archive works
HealthPremium archive

Canadian government signs an agreement with AstraZeneca to procure 100,000 doses of the Evushield COVID-19 antibody therapy for use in high-risk patients

The Canadian government signs an agreement with AstraZeneca to procure 100,000 doses of the Evushield COVID-19 antibody therapy for use in high-risk patients.

By Belfast Herald Newsdesk1 min read

Herald Premium Archive

This report is for subscribers

Sign in or choose a plan to read this report and the complete Premium retrospective archive.

HealthCanadian government signs an agreement with AstraZeneca to procure 100,000 doses of the Evushield COVID-19 antibody therapy for use in high-risk patients

The Canadian government signs an agreement with AstraZeneca to procure 100,000 doses of the Evushield COVID-19 antibody therapy for use in high-risk patients.

View Premium plansBrowse free archive reports